Salud financiera de hoja de balance de Aprea Therapeutics
Salud financiera controles de criterios 6/6
Aprea Therapeutics has a total shareholder equity of $26.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $30.0M and $3.1M respectively.
Información clave
0%
Ratio deuda-patrimonio
US$0
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$28.69m |
| Patrimonio | US$26.87m |
| Total pasivo | US$3.09m |
| Activos totales | US$29.96m |
Actualizaciones recientes sobre salud financiera
Análisis de la situación financiera
Pasivos a corto plazo: APRE's short term assets ($29.6M) exceed its short term liabilities ($3.1M).
Pasivo a largo plazo: APRE has no long term liabilities.
Historial y análisis de deuda-patrimonio
Nivel de deuda: APRE is debt free.
Reducción de la deuda: APRE had no debt 5 years ago.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: APRE has sufficient cash runway for more than a year based on its current free cash flow.
Pronóstico de cash runway: APRE has sufficient cash runway for 1.8 years if free cash flow continues to grow at historical rates of 41.4% each year.